True Rx Insights

Staying with the wrong PBM is riskier than switching. Transitions can be fast, smooth, and more strategic than ever.

To reflect your program’s full value, pharmacy needs a clear, intentional spotlight—not a footnote—during Open Enrollment, backed by real, timely support.

Authorized generics might sound like a budget-friendly choice, and in some cases, they are. But the reality is more complex, and savings aren’t always guaranteed.

How GLP-1s and Measurable Weight Management Programs are Changing the Landscape of Employee Wellness.

Pharmacy access is shrinking nationwide—mail-order pharmacy offers a scalable, patient-centered solution to improve care, reduce costs, and restore equity.

Discover why breaking up with the traditional model could be a smart move for your bottom line and your employees.

Employers shouldn’t have to choose between controlling costs and providing high-quality support for their employees.  Now celebrating its five-year anniversary, True Codes can deliver both.

AI enhances pharmacy benefits, but human connection is essential. Employers must evaluate PBMs for human-led clinical decisions, proactive consultation, and personalized service to improve health outcomes.

Recent FDA changes impact GLP-1 compounding, affecting employer benefits and employee access to weight-loss medications. Employers must evaluate coverage strategies and weight-loss platforms for long-term cost and health outcomes.

300 covered lives on the plan

15,000 covered lives on the plan

6,400 covered lives on the plan

1,660 covered lives on the plan

1,700 covered lives on the plan

Managed Healthcare Executive published a feature interview with True Rx’s Chief Strategy Officer, Adrienne LaBorwit: “PBM-Offered Genomics Testing Could Reshape Prescribing of Medications.”

Adrienne Williams LaBorwit, the company's Chief Strategy Officer, will become Chief Executive Officer (CEO) in January 2026. LaBorwit will succeed Mark Williams, RPh, who will transition from his current role as CEO into his new position as Founder and Chairman. At the same time, Chief Operating Officer Jesse McDonald, PharmD, will assume the newly created role of President of True Rx.

True Rx Health Strategists, the Indiana-based pharmacy benefit manager (PBM) privately owned by a family of pharmacists, today announced the launch of True Outcomes: Diabetes Management, a comprehensive, patient-centered diabetes management program designed for employers. The program draws on True Rx's clinically focused approach, with one dedicated clinician for every ten employees, ensuring personalized care for the hundreds of thousands of patients it serves nationwide.

True Rx Health Strategists, the Indiana-based pharmacy benefit management (PBM) company whose clinically-trained staff cares for hundreds of thousands of patients nationwide, launched a patient-driven collaboration with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs).

What employers need to know about Zepbound's expanded use in obstructive sleep apnea.

An Educational Resource from True Rx Health Strategists

A Point of View Resource from True Rx Health Strategists

A Guide to Weight Loss Medications for Benefits Brokers and Advisors

Solutions to orphan drug management

Avoid cost pitfalls and maintain quality treatment.

Infusion drugs are among the fastest-growing cost drivers for self-funded employers, yet many are leaving significant savings on the table. Are you?

We’ll break down key trends in the upcoming pipeline and provide actionable insights on how to navigate the changing landscape.

How do you offer the care employees need while controlling skyrocketing costs? The good news? It can be done.

Mark Williams and Mark Cuban made the decision to start businesses that promote transparent pricing models that put patient care first.

Learn how to navigate a future of escalating prescription drug costs while still elevating employee health.

How a pharmacogenomics program utilizes gene-based science to guarantee the most effective drug therapies.

Learn how you can be proactive with diabetes management.

We discuss employer health care spend, work absenteeism, and treating obesity with patient care.

Discover benefits and trade-offs of covering GLP-1 drugs for weight loss and smart strategies for diabetes management.